NRx Pharmaceuticals (Nasdaq:NRXP) Announces 2025 Annual Meeting Date and Record Date

Core Points - NRx Pharmaceuticals, Inc. will hold its 2025 Annual Meeting on March 23, 2026, at 10:00 a.m. Eastern Time in a virtual-only format [1] - The record date for stockholders entitled to vote at the meeting is set for February 12, 2026 [1] - The deadline for stockholder proposals and nominations is January 26, 2026, due to the timing of the meeting [4][6] Company Information - NRx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapeutics for central nervous system disorders, including suicidal depression, chronic pain, and PTSD [8] - The company is developing NRX-100 and NRX-101, with NRX-100 receiving Fast Track Designation for treating suicidal ideation in depression and NRX-101 receiving Breakthrough Therapy Designation for suicidal bipolar depression [8] - NRx has filed an Abbreviated New Drug Application for NRX-100 and initiated a New Drug Application filing for the same drug [8]